<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21209873</article-id><article-id pub-id-type="pmc">3013115</article-id><article-id pub-id-type="publisher-id">PONE-D-10-00336</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0015684</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>T Cells</subject></subj-group></subj-group><subj-group><subject>Autoimmunity</subject></subj-group></subj-group><subj-group><subject>Model Organisms</subject><subj-group><subject>Animal Models</subject><subj-group><subject>Mouse</subject></subj-group></subj-group></subj-group><subj-group><subject>Molecular Cell Biology</subject><subj-group><subject>Signal Transduction</subject><subj-group><subject>Signaling Cascades</subject><subj-group><subject>Apoptotic Signaling Cascade</subject></subj-group></subj-group><subj-group><subject>Signaling in Cellular Processes</subject><subj-group><subject>Apoptotic Signaling</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Clinical Immunology</subject><subj-group><subject>Autoimmune Diseases</subject><subj-group><subject>Diabetes Mellitus Type 1</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Apoptosis of Purified CD4<sup>&#x0002b;</sup> T Cell Subsets Is Dominated by Cytokine Deprivation and Absence of Other Cells in New Onset Diabetic NOD Mice</article-title><alt-title alt-title-type="running-head">T Cell Apoptosis in Diabetic NOD Mice</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kaminitz</surname><given-names>Ayelet</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Askenasy</surname><given-names>Enosh M.</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yaniv</surname><given-names>Isaac</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Stein</surname><given-names>Jerry</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Askenasy</surname><given-names>Nadir</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Frankel Laboratory, Center for Stem Cell Research, Schneider Children's Medical Center of Israel, Petach Tikva, Israel</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Bone Marrow Transplant Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Department of Pediatric Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel</addr-line></aff><aff id="aff5"><label>5</label><addr-line>Soroka Medical School, Ben-Gurion University of the Negev, Beer Sheva, Israel</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Unutmaz</surname><given-names>Derya</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">New York University, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>anadir@012.net.il</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: AK NA. Performed the experiments: AK. Analyzed the data: EMA IY JS NA. Wrote the paper: AK EMA IY JS NA.</p></fn></author-notes><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>31</day><month>12</month><year>2010</year></pub-date><volume>5</volume><issue>12</issue><elocation-id>e15684</elocation-id><history><date date-type="received"><day>4</day><month>8</month><year>2010</year></date><date date-type="accepted"><day>22</day><month>11</month><year>2010</year></date></history><permissions><copyright-statement>Kaminitz et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract><sec><title>Background</title><p>Regulatory T cells (Treg) play a significant role in immune homeostasis and self-tolerance. Excessive sensitivity of isolated Treg to apoptosis has been demonstrated in NOD mice and humans suffering of type 1 diabetes, suggesting a possible role in the immune dysfunction that underlies autoimmune insulitis. In this study the sensitivity to apoptosis was measured in T cells from new onset diabetic NOD females, comparing purified subsets to mixed cultures.</p></sec><sec><title>Principal Findings</title><p>Apoptotic cells are short lived in vivo and death occurs primarily during isolation, manipulation and culture. Excessive susceptibility of CD25<sup>&#x0002b;</sup> T cells to spontaneous apoptosis is characteristic of isolated subsets, however disappears when death is measured in mixed splenocyte cultures. In variance, CD25<sup>&#x02212;</sup> T cells display balanced sensitivity to apoptosis under both conditions. The isolation procedure removes soluble factors, IL-2 playing a significant role in sustaining Treg viability. In addition, pro- and anti-apoptotic signals are transduced by cell-to-cell interactions: CD3 and CD28 protect CD25<sup>&#x0002b;</sup> T cells from apoptosis, and in parallel sensitize na&#x000ef;ve effector cells to apoptosis. Treg viability is modulated both by other T cells and other subsets within mixed splenocyte cultures. Variations in sensitivity to apoptosis are often hindered by fast proliferation of viable cells, therefore cycling rates are mandatory to adequate interpretation of cell death assays.</p></sec><sec><title>Conclusions</title><p>The sensitivity of purified Treg to apoptosis is dominated by cytokine deprivation and absence of cell-to-cell interactions, and deviate significantly from measurements in mixed populations. Balanced sensitivity of na&#x000ef;ve/effector and regulatory T cells to apoptosis in NOD mice argues against the concept that differential susceptibility affects disease evolution and progression.</p></sec></abstract><counts><page-count count="11"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Autoimmune insulitis in NOD mice reflects a condition of disturbed immune homeostasis that involves deregulation of both effector (Teff) and regulatory T cells (Treg). Among multiple aberrant mechanisms detected in NOD mice, emphasis on the sensitivity to apoptosis has been intensely investigated as a possible cause of persistent activity of diabetogenic clones and insufficiency of suppressor mechanisms. Suppressor cells encompass a variety of phenotypes and functions that include both naturally occurring and adaptive regulatory T cells (Treg) <xref ref-type="bibr" rid="pone.0015684-Shevach1">&#x0005b;1&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0015684-Sakaguchi1">&#x0005b;4&#x0005d;</xref>. For pragmatic purposes, high-level expression of CD25 (the &#x003b1; chain of the high affinity IL-2 receptor) is used for purification of naturally occurring Treg <xref ref-type="bibr" rid="pone.0015684-Sakaguchi2">&#x0005b;5&#x0005d;</xref>, which is accompanied by the transcription factor FoxP3 <xref ref-type="bibr" rid="pone.0015684-Hori1">&#x0005b;6&#x0005d;</xref>. These subsets are functionally distinct in NOD mice, with CD25<sup>&#x02212;</sup> na&#x000ef;ve/effector T cells (Teff) transferring the disease efficiently into immunocompromized mice, and CD25<sup>&#x0002b;</sup> Treg blocking adoptive disease transfer <xref ref-type="bibr" rid="pone.0015684-Herbelin1">&#x0005b;7&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0015684-Salomon1">&#x0005b;9&#x0005d;</xref>. The same isolation procedure is widely used to assess various functions of Treg <italic>in vitro</italic>, revealing suppression of Teff proliferation and IL-2 production as major mechanisms of Treg-mediated suppression <xref ref-type="bibr" rid="pone.0015684-vonBoehmer1">&#x0005b;10&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0015684-Askenasy1">&#x0005b;12&#x0005d;</xref>. Relative resistance of T cells in general <xref ref-type="bibr" rid="pone.0015684-Colucci1">&#x0005b;13&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-Radosevic1">&#x0005b;14&#x0005d;</xref> and of effector cells in particular <xref ref-type="bibr" rid="pone.0015684-Arreaza1">&#x0005b;15&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-Decallonne1">&#x0005b;16&#x0005d;</xref>, have been attributed a role in disease evolution in NOD mice. These findings question whether differential sensitivities of T cell subsets to apoptosis are involved in dominant effector activity <xref ref-type="bibr" rid="pone.0015684-Yolcu1">&#x0005b;17&#x0005d;</xref>.</p><p>Increased apoptosis of CD4<sup>&#x0002b;</sup>CD25<sup>&#x0002b;/high</sup> T cells isolated by FACS sorting and immunomagnetic antibodies from diabetic patients suggests possible involvement in the pathogenesis this autoimmune disorder <xref ref-type="bibr" rid="pone.0015684-Taams1">&#x0005b;18&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0015684-Jailwala1">&#x0005b;21&#x0005d;</xref>. However, despite the apparent increased susceptibility to apoptosis, Treg are found at equal or higher numbers in new onset diabetics and display primarily functional deficits <xref ref-type="bibr" rid="pone.0015684-Kukreja1">&#x0005b;22&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0015684-Putnam1">&#x0005b;25&#x0005d;</xref>. As a systemic autoimmune disorder, high levels of circulating Treg reflect a physiological effort to counteract inflammatory reaction, whereas increased susceptibility to apoptosis is an apparent detrimental mechanism. Likewise, Treg levels are steady in NOD females in late stages of destructive insulitis <xref ref-type="bibr" rid="pone.0015684-You1">&#x0005b;26&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-Mellanby1">&#x0005b;27&#x0005d;</xref>, and are found at excessive numbers in mutant mice deficient in Fas-ligand (<italic>gld</italic>) <xref ref-type="bibr" rid="pone.0015684-Mohamood1">&#x0005b;28&#x0005d;</xref>. Although defective negative regulation in <italic>gld</italic> mice might lead to elevated Treg fractions within the generalized lymphoproliferative state, it is unclear why apoptotic cells are collected from wild type mice. Unlike the proliferative anergy displayed by Treg <italic>in vitro</italic> <xref ref-type="bibr" rid="pone.0015684-Kuniyasu1">&#x0005b;29&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-Gavin1">&#x0005b;30&#x0005d;</xref>, this subset appears to cycle at faster rates <italic>in vivo</italic> <xref ref-type="bibr" rid="pone.0015684-Mohamood1">&#x0005b;28&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-Fisson1">&#x0005b;31&#x0005d;</xref>, a possible cause of increased mortality <xref ref-type="bibr" rid="pone.0015684-Yolcu1">&#x0005b;17&#x0005d;</xref>. Alternatively, it is possible that Treg are particularly susceptible to manipulation during isolation, manipulation and culture and their death is primarily related to the processing procedure. Our prior studies have demonstrated efficient clearance of dead cells from the bone marrow, as determined by intravital microscopy and focused irradiation of labeled cells at the fluorochrome wavelength <xref ref-type="bibr" rid="pone.0015684-Askenasy2">&#x0005b;32&#x0005d;</xref>. We therefore hypothesize that dead cells are scarcely found in tissues under steady state conditions, and death might occur during manipulation.</p><p>The sensitivity of purified Treg is modulated by the proliferation rates, cytokines, TCR engagement and the state of activation, and most important by feedback interactions with cytotoxic T cells <xref ref-type="bibr" rid="pone.0015684-Yolcu1">&#x0005b;17&#x0005d;</xref>. Isolation of T cell subsets according to CD25 expression relies on functional assays, where CD25<sup>&#x02212;</sup> are largely composed of na&#x000ef;ve/effector cells and CD25<sup>&#x0002b;</sup> correspond to an enriched fraction of naturally occurring Treg expressing FoxP3. For example, CD25<sup>&#x02212;</sup> T cells induce insulitis in immunocompromized hosts, whereas CD25<sup>&#x0002b;</sup> T cells suppress adoptive disease transfer <xref ref-type="bibr" rid="pone.0015684-Herbelin1">&#x0005b;7&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0015684-Salomon1">&#x0005b;9&#x0005d;</xref>. In this study we assessed the sensitivity of CD25<sup>&#x02212;</sup> and CD25<sup>&#x0002b;</sup> T cells derived from new onset diabetic mice to spontaneous apoptosis in cultures of purified cells and mixed populations. We found that the isolation procedure is a dominant factor that affects the susceptibility of CD25<sup>&#x0002b;</sup> T cells. Apoptosis of both effector and regulatory cells is modulated both by IL-2 and cell-to-cell interactions that transduce TCR-associated and costimulatory signals.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>T cells isolated from lymphoid organs exhibit variations in spontaneous apoptosis</title><p>The procedure of immunomagnetic isolation, composed of negative selection of CD4<sup>&#x0002b;</sup> T cell and positive selection for CD25 within this subset, results in marked variability in lymphocyte viability. These populations are functionally distinct, with CD25<sup>&#x02212;</sup> cells adoptively transferring diabetes into 80&#x00025; of NOD.SCID mice, whereas CD25<sup>&#x0002b;</sup> T cells lacking diabetogenic activity and repressing disease transfer <xref ref-type="bibr" rid="pone.0015684-Salomon1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-You1">&#x0005b;26&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-Mellanby1">&#x0005b;27&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-Kuniyasu1">&#x0005b;29&#x0005d;</xref>. A series of 19 isolation procedures showed initial contents of dead cells ranging from 7.6&#x000b1;6.9&#x00025; (range 0.4&#x00025;&#x02013;20&#x00025;) and 14.3&#x000b1;10.3&#x00025; (range 0.8&#x00025;&#x02013;33&#x00025;) for CD25<sup>&#x02212;</sup> and CD25<sup>&#x0002b;</sup> subsets respectively. Limiting the use of these samples to 10&#x00025; dead cells in each individual subset, 13 experiments were used with mean contents of 3.7&#x000b1;2.8&#x00025; and 6.8&#x000b1;4&#x00025; non-viable CD25<sup>&#x02212;</sup> and CD25<sup>&#x0002b;</sup> cells, respectively. These values fall within the range previously reported for the frequency of apoptotic cells following cyclophosphamide challenge in vivo <xref ref-type="bibr" rid="pone.0015684-Colucci1">&#x0005b;13&#x0005d;</xref>. Notably, differential staining showed 7-AAD uptake in 89&#x000b1;5&#x00025; of the cells which were negative for Annexin-V, indicating non-specific membrane permeabilization as a feature of non-apoptotic death. Since CD25<sup>&#x0002b;</sup> T cells are more sensitive to death during the preparation procedure (p&#x0003c;0.05 vs CD25<sup>&#x02212;</sup>), these data present a caution to experiments based on detection of differential sensitivity to apoptosis of purified cells.</p><p>To evaluate the precision of measurements of dead cells in fresh samples, NOD mice were infused with 5&#x000d7;10<sup>7</sup> PKH-labeled dead autologous splenocytes. After 2 hours, 12.8&#x000b1;3.4&#x00025; of the infused cells were found in the spleens and mesenteric lymph nodes of the NOD recipients. These cells were not detected after 24 hours, demonstrating fast clearance of dead cells entrapped in the lymphoid organs.</p></sec><sec id="s2b"><title>Isolated CD25<sup>&#x0002b;</sup> T cells are more sensitive to apoptosis than mixed cultures</title><p>To determine possible variations in susceptibility of CD4<sup>&#x0002b;</sup> T cell subsets to apoptosis, cells were incubated for 48 hours under conditions of cytokine deprivation. CD4<sup>&#x0002b;</sup> T cells isolated from wild type (C57BL/6), prediabetic (14 weeks) and diabetic NOD mice display disproportional sensitivity to apoptosis: 21&#x02013;33&#x00025; and 48&#x02013;62&#x00025; of CD25<sup>&#x02212;</sup> and CD25<sup>&#x0002b;</sup> cells succumb to apoptosis respectively (p&#x0003c;0.01, <xref ref-type="fig" rid="pone-0015684-g001">Figure 1A</xref>). Increased apoptosis of CD25<sup>&#x0002b;</sup> cells isolated from new onset diabetic mice is consistent with the reported sensitivities of CD25<sup>&#x0002b;</sup> T cells isolated from wild type and <italic>gld</italic> (FasL-defective) mice <xref ref-type="bibr" rid="pone.0015684-Mohamood1">&#x0005b;28&#x0005d;</xref> as well as in humans <xref ref-type="bibr" rid="pone.0015684-Taams1">&#x0005b;18&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0015684-Jailwala1">&#x0005b;21&#x0005d;</xref>. However, measurements of apoptosis performed by gating of CD4<sup>&#x0002b;</sup> T cell subsets within mixed splenocyte populations show a very different situation (<xref ref-type="fig" rid="pone-0015684-g001">Figure 1A</xref>). Increased mortality of CD25<sup>&#x0002b;</sup> T cells is primarily a result of the isolation procedure (p&#x0003c;0.005), a feature that is much less accentuated in the CD25<sup>&#x02212;</sup> subset. Dissociation between CD25<sup>low</sup> (45&#x00025;) and CD25<sup>high</sup> (55&#x00025;) subsets (<xref ref-type="fig" rid="pone-0015684-g001">Figure 1B</xref>) in new onset diabetic NOD females disclosed excessive apoptosis of isolated CD25<sup>high</sup> cells (p&#x0003c;0.001 vs CD25<sup>low</sup>), suggesting particular dependence on factors released by adjacent cells such as IL-2. Distinct behavior within the CD4<sup>&#x0002b;</sup> subset was further assessed in reference to FoxP3 expression (<xref ref-type="fig" rid="pone-0015684-g001">Figure 1C</xref>), showing increased sensitivity to apoptosis of FoxP3<sup>&#x0002b;</sup> cells (p&#x0003c;0.001 vs FoxP3<sup>&#x02212;</sup>) in particular within the isolated CD25<sup>&#x0002b;</sup> subset (p&#x0003c;0.001 vs gated). These data document increased susceptibility to apoptosis in culture of CD4<sup>&#x0002b;</sup> T cells displaying a phenotype of naturally occurring Treg derived from wild type and NOD mice.</p><fig id="pone-0015684-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0015684.g001</object-id><label>Figure 1</label><caption><title>Impact of cell isolation on sensitivity to apoptosis.</title><p><bold>A</bold>. Apoptosis of CD4<sup>&#x0002b;</sup>CD25<sup>&#x02212;</sup> and CD4<sup>&#x0002b;</sup>CD25<sup>&#x0002b;</sup> subsets measured after 48 hours in isolated cell suspensions (n&#x0200a;&#x0003d;&#x0200a;5) and by gating in mixed cultures (n&#x0200a;&#x0003d;&#x0200a;5). Cells were harvested from wild type C57BL/6, prediabetic NOD females aged 14 weeks and new onset diabetic NOD mice. Representative measurements of 7-AAD and Annexin-V incorporation are shown for isolated and mixed populations (gated) from diabetic NOD females. <bold>B</bold>. Differential apoptosis in reference to low and high CD25 expression measured in isolated CD25<sup>&#x0002b;</sup> subsets (n&#x0200a;&#x0003d;&#x0200a;4) and by gating in mixed cultures (n&#x0200a;&#x0003d;&#x0200a;5). <bold>C</bold>. Spontaneous apoptosis in reference to FoxP3 expression in the isolated CD25<sup>&#x0002b;</sup> subset (n&#x0200a;&#x0003d;&#x0200a;3) and in mixed cultures (n&#x0200a;&#x0003d;&#x0200a;3).</p></caption><graphic xlink:href="pone.0015684.g001"/></fig></sec><sec id="s2c"><title>Soluble factors and cell-to-cell interactions affect cell viability</title><p>Protection of CD25<sup>&#x0002b;</sup> T cells from apoptosis by adjacent cells might be mediated by cytokines and cell-to-cell interactions. To determine the role of soluble factors, cells were incubated with conditioned medium of CD25<sup>&#x02212;</sup> T cells stimulated in plates containing bound anti-CD3 and CD28 antibodies <xref ref-type="bibr" rid="pone.0015684-Banz1">&#x0005b;33&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-DAlise1">&#x0005b;34&#x0005d;</xref>. Conditioned medium had little influence on apoptotic death of isolated CD25<sup>&#x02212;</sup> cells and partially reversed the excessive death of CD25<sup>&#x0002b;</sup> cells (p&#x0003c;0.001, <xref ref-type="fig" rid="pone-0015684-g002">Figure 2A</xref>). Therefore, putative Treg are partially protected from apoptosis in culture by soluble factors released from adjacent populations. To determine the major subsets that affect the sensitivity to apoptosis, B lymphocytes and myeloid cells (GR-1<sup>&#x0002b;</sup> and MAC-1<sup>&#x0002b;</sup>) were depleted from the mixed cultures (<xref ref-type="fig" rid="pone-0015684-g002">Figure 2B</xref>). Since the isolation procedure appears to be a process that sensitizes to apoptosis, we preferred exclusion of cells rather than combining isolated cell subsets. In variance from the small effect of depletion on CD25<sup>&#x02212;</sup> cells, exclusion of B lymphocytes and myeloid cells from the cultures partially protected CD25<sup>&#x0002b;</sup> T cells from apoptosis (p&#x0003c;0.001). Overall, T cells and other constituents of the spleen support the viability of CD25<sup>&#x0002b;</sup> Treg in culture through release of soluble factors, and possibly through cell-to-cell interactions.</p><fig id="pone-0015684-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0015684.g002</object-id><label>Figure 2</label><caption><title>Soluble and cellular factors affecting susceptibility to apoptosis.</title><p><bold>A</bold>. CD25<sup>&#x02212;</sup> and CD25<sup>&#x0002b;</sup> T cells isolated from new onset diabetic NOD females were incubated for 48 hours in conditioned medium from CD25<sup>&#x02212;</sup> T cells stimulated with surface-bound anti CD3 and anti-CD28 antibodies (n&#x0200a;&#x0003d;&#x0200a;3). Data are compared to corresponding measurements of isolated cells and mixed cultures. <bold>B</bold>. Spontaneous apoptosis after 48 hours of culture of isolated CD25<sup>&#x0002b;</sup> T cells (n&#x0200a;&#x0003d;&#x0200a;4) and gated subsets in mixed cultures (n&#x0200a;&#x0003d;&#x0200a;5) following B220, GR-1 and MAC-1 depletion (n&#x0200a;&#x0003d;&#x0200a;4). <bold>C</bold>. Equal numbers of isolated CD25<sup>&#x02212;</sup> and CD25<sup>&#x0002b;</sup> T cells from diabetic NOD mice were mixed for determination of apoptosis after 48 hours of culture in the CD25&#x0002b; subset (gate). Data are representative of four independent incubations.</p></caption><graphic xlink:href="pone.0015684.g002"/></fig><p>Despite the apparent sensitization to apoptosis during the isolation procedure, the distinct effect on CD4<sup>&#x0002b;</sup>CD25<sup>&#x02212;</sup> cells on viability of isolates Treg was performed in co-culture experiments. Incubation of isolated CD4<sup>&#x0002b;</sup>CD25<sup>&#x0002b;</sup> T cells with an equal number of isolated CD4<sup>&#x0002b;</sup>CD25<sup>&#x02212;</sup> was sufficient to reverse susceptibility of the former to spontaneous apoptosis (<xref ref-type="fig" rid="pone-0015684-g002">Figure 2C</xref>) and to restore balanced sensitivity to apoptosis characteristic of mixed cultures (<xref ref-type="fig" rid="pone-0015684-g001">Figure 1A</xref>).</p></sec><sec id="s2d"><title>IL-2 induces cycling and improves the viability of CD25<sup>&#x0002b;</sup> T cells</title><p>IL-2 sensitizes T cells to apoptosis <xref ref-type="bibr" rid="pone.0015684-Lenardo1">&#x0005b;35&#x0005d;</xref>, however in an apparent paradoxal manner cytokine withdrawal also results in marked increase in susceptibility of Treg cells to apoptosis <xref ref-type="bibr" rid="pone.0015684-Pandiyan1">&#x0005b;36&#x0005d;</xref>. The primary cytokine candidate of interaction between Treg and na&#x000ef;ve/effector T cells is supplementation of IL-2, an essential cytokine that is avidly consumed and supports expansion, survival and activity of Treg cells <xref ref-type="bibr" rid="pone.0015684-Yarkoni1">&#x0005b;37&#x0005d;</xref>. Exogenous IL-2 supplementation to isolated CD25<sup>&#x0002b;</sup> T cells has a remarkable anti-apoptotic effect on CD25<sup>&#x0002b;</sup> T cells (p&#x0003c;0.001, <xref ref-type="fig" rid="pone-0015684-g002">Figure 2A</xref>) while sensitizing CD25<sup>&#x02212;</sup> cells to apoptosis (p&#x0003c;0.001). Decreased fractional death is partially caused by IL-2-mediated stimulation of CD25<sup>&#x0002b;</sup> T cell proliferation (p&#x0003c;0.05, <xref ref-type="fig" rid="pone-0015684-g003">Figure 3B</xref>), diluting the apoptotic cells within a fast cycling viable population. Likewise, IL-2 protects CD25<sup>&#x0002b;</sup> T cells from apoptosis in mixed cultures (p&#x0003c;0.01, <xref ref-type="fig" rid="pone-0015684-g003">Figure 3C</xref>), a phenomenon also associated with faster cycling of this subset (<xref ref-type="fig" rid="pone-0015684-g003">Figure 3D</xref>). Therefore, pharmacological concentrations of IL-2 improve the survival of CD25<sup>&#x0002b;</sup> T cells, both as isolated subsets and within bulk splenocyte populations. Furthermore, the endogenous supply of IL-2 in mixed cultures is insufficient to attain the maximal protective effect over cell viability conferred by this cytokine.</p><fig id="pone-0015684-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0015684.g003</object-id><label>Figure 3</label><caption><title>Influence of IL-2 on CD4<sup>&#x0002b;</sup> T cell apoptosis.</title><p><bold>A</bold>. Apoptosis of CD4<sup>&#x0002b;</sup>CD25<sup>&#x02212;</sup> (n&#x0200a;&#x0003d;&#x0200a;5) and CD4<sup>&#x0002b;</sup>CD25<sup>&#x0002b;</sup> T cells (n&#x0200a;&#x0003d;&#x0200a;4) isolated from new onset diabetic NOD females and incubated for 48 hours with and without 2000 U/ml IL-2. <bold>B</bold>. Demonstrative measurements of proliferation rates of isolated CD25<sup>&#x02212;</sup> and CD25<sup>&#x0002b;</sup> cells as determined from CFSE dilution (representative of 4 independent measurements). <bold>C</bold>. Impact of exogenous IL-2 supplementation on apoptosis measured by gating on CD25<sup>&#x02212;</sup> and CD25<sup>&#x0002b;</sup> subsets in mixed cultures (n&#x0200a;&#x0003d;&#x0200a;4). <bold>D</bold>. Demonstrative plots of CFSE dilution in gated CD4<sup>&#x0002b;</sup> subsets within mixed cultures (representative of 4 measurements).</p></caption><graphic xlink:href="pone.0015684.g003"/></fig></sec><sec id="s2e"><title>CD3/CD28 stimulation protects isolated CD25<sup>&#x0002b;</sup> T cells from apoptosis</title><p>Another parameter attenuated by cell isolation is interaction between various cell subsets, including TCR-associated stimulation. Such interactions are stipulated by the observation that the suppressor activity of CD25<sup>&#x0002b;</sup> T cells depends on cell-to-cell interactions <xref ref-type="bibr" rid="pone.0015684-Takahashi1">&#x0005b;38&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-Thornton1">&#x0005b;39&#x0005d;</xref> and the sensitivity to apoptosis is reciprocally modulated in coincubations of effector and suppressor cells <xref ref-type="bibr" rid="pone.0015684-Banz1">&#x0005b;33&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-DAlise1">&#x0005b;34&#x0005d;</xref>. Isolated CD25<sup>-</sup> cells display increased rates of spontaneous apoptosis upon CD3 stimulation with no apparent additional effect of CD28 costimulation (p&#x0003c;0.05, <xref ref-type="fig" rid="pone-0015684-g004">Figure 4A</xref>), except stimulation of fast cycling (p&#x0003c;0.01, <xref ref-type="fig" rid="pone-0015684-g004">Figure 4B</xref>). Although proliferation sensitizes na&#x000ef;ve T lymphocytes to apoptosis, expansion of viable cells dilutes the dead fractions. Both stimulatory signals protect isolated CD25<sup>&#x0002b;</sup> T cells from spontaneous apoptosis (p&#x0003c;0.001, <xref ref-type="fig" rid="pone-0015684-g004">Figure 4A</xref>), with significantly smaller effects on proliferation (<xref ref-type="fig" rid="pone-0015684-g004">Figure 4B</xref>). Isolated CD25<sup>&#x0002b;</sup> T cells maintain fractional expression of the IL-2 receptor and FoxP3 under CD3/CD28 stimulation (<xref ref-type="fig" rid="pone-0015684-g004">Figure 4C</xref>). These data are consistent with prior demonstration of protective effects of TCR-associated stimulation over isolated Treg cells and are consistent with successful <italic>ex vivo</italic> expansion of this subset by these stimulatory pathways <xref ref-type="bibr" rid="pone.0015684-Tang1">&#x0005b;40&#x0005d;</xref>.</p><fig id="pone-0015684-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0015684.g004</object-id><label>Figure 4</label><caption><title>Sensitivity to apoptosis of isolated CD4<sup>&#x0002b;</sup> T cells under CD3 and CD28 stimulation.</title><p>CD25<sup>&#x02212;</sup> and CD25<sup>&#x0002b;</sup> T cells isolated from new onset diabetic NOD mice were stimulated with beads conjugated to anti-CD3 and anti-CD28. <bold>A</bold>. Apoptosis during 48 hours of incubation under CD3 (n&#x0200a;&#x0003d;&#x0200a;4) and CD3/CD28 stimulation (n&#x0200a;&#x0003d;&#x0200a;4). <bold>B</bold>. Proliferation rates determined from CFSE dilution. <bold>C</bold>. Isolated CD25<sup>&#x02212;</sup> T cells convert to express CD25 without FoxP3 priming during 48 hours of CD3/CD28 stimulation. Isolated CD25&#x0002b; T cells sustain Cd25 and FoxP3 expression during Cd3/Cd28 stimulation. <bold>D</bold>. Proliferation rates of cells unresponsive to stimulation (CD25<sup>&#x02212;</sup>) and the subset that upregulates CD25 expression (CD25<sup>&#x02212;</sup>&#x02192;CD25<sup>&#x0002b;</sup>) and representative plots of CFSE dilution. <bold>E</bold>. Fractional apoptosis of responsive and unresponsive CD25<sup>&#x02212;</sup> T cells under CD3/CD28 stimulation (n&#x0200a;&#x0003d;&#x0200a;4) and representative plots of apoptosis.</p></caption><graphic xlink:href="pone.0015684.g004"/></fig><p>Further analysis of isolated CD25<sup>&#x02212;</sup> T cells reveals that CD3/CD28 stimulation defines two distinct subsets. A minor fraction of cells remain negative for the IL-2 receptor (<xref ref-type="fig" rid="pone-0015684-g004">Figure 4C</xref>), proliferate at slow rates (<xref ref-type="fig" rid="pone-0015684-g004">Figure 4D</xref>) and are sensitive to apoptosis (p&#x0003c;0.001, <xref ref-type="fig" rid="pone-0015684-g004">Figure 4E</xref>). The major fraction is induced to express CD25 and CD69 without priming FoxP3 expression (<xref ref-type="fig" rid="pone-0015684-g004">Figure 4C</xref>), proliferate at faster rates (p&#x0003c;0.01, <xref ref-type="fig" rid="pone-0015684-g004">Figure 4D</xref>) and display stable sensitivity to apoptosis (<xref ref-type="fig" rid="pone-0015684-g004">Figure 4E</xref>). Although responsive cells (CD25<sup>&#x02212;</sup>&#x02192;CD25<sup>&#x0002b;</sup>) display relatively stable levels of fractional apoptosis, fast turnover of viable cells (<xref ref-type="fig" rid="pone-0015684-g004">Figure 4D</xref>) dilutes the true numbers of activated apoptotic cells. Taken together, CD3 and CD28 stimulation present dissociated effects on isolated CD4<sup>&#x0002b;</sup> subsets: increase the sensitivity of isolated CD25<sup>&#x02212;</sup> T cells to apoptosis irrespective of the proliferation rates, and improve the viability of isolated CD25<sup>&#x0002b;</sup> T cells.</p></sec><sec id="s2f"><title>CD28 costimulation sensitizes CD25&#x02212; T cells to apoptosis in mixed cultures</title><p>Measurements of Treg cell apoptosis in CD3-activated mixed cultures are limited by CD25 expression in na&#x000ef;ve/effector CD4<sup>&#x0002b;</sup> T cells as a feature of activation. Evaluation of mixed cultures reveals conversion to express CD25 of 85&#x00025; of the CD4<sup>&#x0002b;</sup>CD25<sup>&#x02212;</sup> T cells (<xref ref-type="fig" rid="pone-0015684-g005">Figure 5A</xref>), making the contribution naturally occurring CD25<sup>&#x0002b;</sup> (7.6&#x000b1;1.3&#x00025;) and FoxP3<sup>&#x0002b;</sup> cells (10.9&#x000b1;3&#x00025;) relatively insignificant. Assuming a negligible contribution of Treg to the fraction of CD3-activated CD4<sup>&#x0002b;</sup> T cells, the responsive cells display superior survival in mixed cultures (p&#x0003c;0.001 vs isolated cells, <xref ref-type="fig" rid="pone-0015684-g005">Figure 5B</xref>). Decreased fractional apoptosis is partially attributed to fast cycling of viable cells (<xref ref-type="fig" rid="pone-0015684-g005">Figure 5C</xref>), diluting the apoptotic subset. Superposed CD28 costimulation results in remarkable high death rates on unresponsive cells (<xref ref-type="fig" rid="pone-0015684-g005">Figure 5D</xref>), which is even more pronounced in mixed cultures (p&#x0003c;0.001 vs isolated cells). Notably, the proliferative responses to CD3/CD28 stimulation are largely amplified in mixed cultures (p&#x0003c;0.005, <xref ref-type="fig" rid="pone-0015684-g005">Figure 5E</xref>), suggesting synergism with other factors secreted by adjacent cells. Overall, these data demonstrate that CD3 stimulation activates na&#x000ef;ve/effector CD25<sup>&#x02212;</sup> T cells to proliferate at fast rates and display activation markers. Expansion of viable cells is the likely reason for decreased fractional apoptosis of cells responsive to stimulation. Independently, CD28 costimulation sensitizes both unresponsive and responsive subsets to apoptosis, though the latter is hindered by a 4-fold increase in cycling rates.</p><fig id="pone-0015684-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0015684.g005</object-id><label>Figure 5</label><caption><title>Apoptosis under CD3/CD28 stimulation.</title><p><bold>A</bold>. Representative plots demonstrating upregulation of CD25 in response to CD3/CD28 stimulation in mixed splenocyte cultures. <bold>B</bold>. Spontaneous apoptosis in isolated (n&#x0200a;&#x0003d;&#x0200a;4) and gated cells (n&#x0200a;&#x0003d;&#x0200a;5) in reference to responsiveness (CD25 expression) to CD3-activation, assuming negligible contribution of naturally occurring CD25<sup>&#x0002b;</sup> T cells in mixed cultures. <bold>C</bold>. Proliferation rates under CD3-activation of responsive (CD25<sup>&#x02212;</sup>&#x02192;CD25<sup>&#x0002b;</sup>) and non-responsive (CD25<sup>&#x02212;</sup>) subsets in isolated CD25<sup>&#x02212;</sup> T cells (n&#x0200a;&#x0003d;&#x0200a;4) and in mixed cultures (gated, n&#x0200a;&#x0003d;&#x0200a;5). <bold>D</bold>. Fractional apoptosis of responsive and non-responsive cells to CD3/CD28 stimulation in mixed cultures (n&#x0200a;&#x0003d;&#x0200a;5). <bold>E</bold>. Proliferation rates under CD3/CD28 stimulation.</p></caption><graphic xlink:href="pone.0015684.g005"/></fig></sec></sec><sec id="s3"><title>Discussion</title><p>Measurements performed in isolated cell subsets are easy, precise and allow significant manipulation of multiple experimental variables. Here we provide evidence that assessment of spontaneous apoptosis is dominated by isolation procedures and culture conditions. The first significant observation is wide variability in cell viability in fresh lymphocyte samples, which question whether such measurements can be used to assess differential apoptosis in vivo under various physiological and pathological conditions. Successful harvesting of cells from new onset diabetic mice with less than 1&#x00025; dead cells, predominant staining with death probes and low specific staining of apoptosis imply that few apoptotic cells are found in lymphoid organs in situ. Although T cells are submitted to negative regulation both in the thymus and the periphery, dead cells are short lived in vivo due to efficient clearance mechanisms <xref ref-type="bibr" rid="pone.0015684-Askenasy3">&#x0005b;41&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0015684-Asquith1">&#x0005b;44&#x0005d;</xref>. Our current observations argue that the differences in fresh samples might originate from differential susceptibilities to death under various pathological conditions, which are accentuated by the isolation procedure. Although susceptibility to apoptosis is a feature of cells isolated from wild type and NOD mice, measurements of apoptosis have been used to suggest that increased apoptosis of CD4<sup>&#x0002b;</sup>CD25<sup>high</sup> T cells, obtained either by immunomagnetic isolation or FACS sorting, is a mechanism involved in the pathogenesis of autoimmune diabetes <xref ref-type="bibr" rid="pone.0015684-Taams1">&#x0005b;18&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0015684-Jailwala1">&#x0005b;21&#x0005d;</xref>. These data have to be carefully evaluated when used to monitor disease evolution <xref ref-type="bibr" rid="pone.0015684-GlisicMilosavljevic2">&#x0005b;45&#x0005d;</xref>, as penetration of death probes might be a primary consequence of membrane permeabilization during isolation rather than a physiological feature of the disease <xref ref-type="bibr" rid="pone.0015684-Klein1">&#x0005b;46&#x0005d;</xref>. Likewise, it remains to be determined what is the impact of isolation on the suppressive function of apoptosis-sensitive, non-proliferating Treg on effector cells in diabetic patients <xref ref-type="bibr" rid="pone.0015684-Schneider1">&#x0005b;47&#x0005d;</xref> and NOD mice <xref ref-type="bibr" rid="pone.0015684-DAlise1">&#x0005b;34&#x0005d;</xref>.</p><p>Our data confirm the higher sensitivity of isolated CD25<sup>&#x0002b;</sup> T cells to apoptosis <xref ref-type="bibr" rid="pone.0015684-Taams1">&#x0005b;18&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0015684-Jailwala1">&#x0005b;21&#x0005d;</xref>, and reciprocal modulation of this sensitivity between na&#x000ef;ve/effector and suppressor T cells <xref ref-type="bibr" rid="pone.0015684-Banz1">&#x0005b;33&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-DAlise1">&#x0005b;34&#x0005d;</xref>. However, all parameters measured in isolated subsets differed from mixed splenocyte cultures, including proliferation rates, apoptotic death, responses to cytokines, TCR-associated stimulation and costimulation. These functions reflect primarily transition to controlled yet arbitrary culture conditions that differ substantially from the physiological environment of these cells. Treg operate within the infiltrates at the site of inflammation <xref ref-type="bibr" rid="pone.0015684-Chen1">&#x0005b;48&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-PearlYafe1">&#x0005b;49&#x0005d;</xref>, under continuously changing cytokine and cellular environments and antigenic stimuli <xref ref-type="bibr" rid="pone.0015684-Askenasy1">&#x0005b;12&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-vonHerrath1">&#x0005b;50&#x0005d;</xref>. We have previously postulated that transition to arbitrary in vitro culture conditions causes proliferative anergy <xref ref-type="bibr" rid="pone.0015684-Yarkoni1">&#x0005b;37&#x0005d;</xref>, whereas Treg cycle at faster rates than na&#x000ef;ve/effector T cells in vivo <xref ref-type="bibr" rid="pone.0015684-Mohamood1">&#x0005b;28&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-Fisson1">&#x0005b;31&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-Klein1">&#x0005b;46&#x0005d;</xref>. CD25<sup>&#x02212;</sup> na&#x000ef;ve/effector cells display a relatively autonomous behavior in respect to the culture conditions <xref ref-type="bibr" rid="pone.0015684-DAlise1">&#x0005b;34&#x0005d;</xref>, however elimination of T cells and other cell subsets increases the susceptibility of isolated Treg to apoptosis, by removing both soluble factors and signals mediated by cell-to-cell interactions. We attempted to reduce differences originating from the isolation procedure per se by exposure of the mixed cultures to the same processing technique without performing the separation. Therefore, starting from fresh samples with similar contents of dead cells, the variations in cell behavior originate primarily from extrinsic factors under our culture conditions. Comparative analysis showed that both pro- and anti-apoptotic factors secreted by other cells within the culture affect the viability of CD25<sup>&#x0002b;</sup> and CD25<sup>high</sup>FoxP3<sup>&#x0002b;</sup> T cells.</p><p>Exogenous IL-2 supplementation reversed the excessive death of isolated CD25<sup>&#x0002b;</sup> T cells and restored their proliferative activity, identifying this cytokine as an anti-apoptotic factor secreted by other cell types. IL-2 is produced only by effector and some adaptive Treg, but not by naturally occurring Treg cells <xref ref-type="bibr" rid="pone.0015684-Bluestone2">&#x0005b;51&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-Raimondi1">&#x0005b;52&#x0005d;</xref>, and inhibition of its secretion from na&#x000ef;ve/cytotoxic T cells is a major mechanism of suppression <xref ref-type="bibr" rid="pone.0015684-Kuniyasu1">&#x0005b;29&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-Takahashi1">&#x0005b;38&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-Thornton1">&#x0005b;39&#x0005d;</xref>. The ensuing state of cytokine deprivation induces apoptosis in effector cells <xref ref-type="bibr" rid="pone.0015684-Pandiyan2">&#x0005b;53&#x0005d;</xref>, and also serves as a regulatory feedback mechanism that downsizes Treg function <xref ref-type="bibr" rid="pone.0015684-Yarkoni1">&#x0005b;37&#x0005d;</xref> towards termination of the inflammatory reaction <xref ref-type="bibr" rid="pone.0015684-Yolcu1">&#x0005b;17&#x0005d;</xref>. In addition to an essential role of this cytokine in Treg development and peripheral function <xref ref-type="bibr" rid="pone.0015684-Malek1">&#x0005b;54&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-Nelson1">&#x0005b;55&#x0005d;</xref>, the requirement for its exogenous supplementation has been documented in numerous prior in vitro studies of isolated CD25<sup>&#x0002b;</sup> T cells <xref ref-type="bibr" rid="pone.0015684-Takahashi1">&#x0005b;38&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0015684-Tang1">&#x0005b;40&#x0005d;</xref> and in vivo <xref ref-type="bibr" rid="pone.0015684-Tang2">&#x0005b;56&#x0005d;</xref>. Furthermore, exogenous IL-2 supplementation improves Treg viability in mixed cultures, associating expression of the high affinity IL-2 receptor with responsiveness to the cognate ligand. These data also indicate that baseline IL-2 production in mixed cultures is insufficient to exert maximal protection of Treg from apoptosis. Although the isolation procedure also eliminates other cytokines released by adjacent cells that simulate the activity of IL-2 through activation of other receptors <xref ref-type="bibr" rid="pone.0015684-Pandiyan1">&#x0005b;36&#x0005d;</xref>, its relative deficiency in the inflammatory infiltrates might contribute to dominant diabetogenic cell activity in NOD mice <xref ref-type="bibr" rid="pone.0015684-Tang2">&#x0005b;56&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-Serreze1">&#x0005b;57&#x0005d;</xref>.</p><p>Partial reversal of Treg hypersensitivity to apoptosis by soluble factors in conditioned medium indicates that cellular interactions affect viability. Similar to the requirement for cell-to-cell interactions to attain Treg-mediated suppression of responder cells <xref ref-type="bibr" rid="pone.0015684-Thornton1">&#x0005b;39&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-Tang1">&#x0005b;40&#x0005d;</xref>, reciprocal signals modulate the sensitivity to apoptosis. Both CD3 stimulation and CD28 costimulation converge to impose additive effects on the viability of isolated Treg, which serve as survival factors independent of IL-2 <xref ref-type="bibr" rid="pone.0015684-Banz1">&#x0005b;33&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-DAlise1">&#x0005b;34&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-Tang1">&#x0005b;40&#x0005d;</xref>. Antigenic stimulation is generally necessary to initiate Treg proliferation <xref ref-type="bibr" rid="pone.0015684-Bienvenu1">&#x0005b;58&#x0005d;</xref>, but TCR engagement is not required for functional activation <xref ref-type="bibr" rid="pone.0015684-Khoruts1">&#x0005b;59&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-Thornton2">&#x0005b;60&#x0005d;</xref>. This dissociation between Treg function and proliferation might be responsible for the relative resistance to apoptosis <xref ref-type="bibr" rid="pone.0015684-Kuniyasu1">&#x0005b;29&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-Gavin1">&#x0005b;30&#x0005d;</xref>. At the same time, CD3/CD28 stimulation sensitizes isolated na&#x000ef;ve/effector cells to spontaneous death in culture. Robust proliferation induced by CD3/CD28 stimulation hinders the real sensitivities to apoptosis, as dead cells are diluted within fast-expanding viable cells. Therefore, measurements of cell death should include proliferation rates to determine the true meaning of fractional apoptosis determined under various stimulatory conditions. The evident sensitization to apoptosis of isolated CD25<sup>&#x02212;</sup> na&#x000ef;ve/effector T cells by CD3 ligation was less pronounced in mixed cultures, in particular the responsive subset. In variance, CD28 appears to increase the susceptibility to spontaneous apoptosis despite fast cycling of the stimulated cells, likely through indirect mechanisms that might involve stimulation of cytokine secretion. Nevertheless, these data demonstrate significant variations in susceptibility to apoptosis induced by cell isolation, which attenuates the differential responses to TCR-associated stimulation and costimulation. The presence of adjacent cells involves both pro- and anti-apoptotic signals even under conditions that mediate hyperstimulation of effector cells.</p><p>Data presented here emphasize that measurements apoptosis in isolated cell subsets deviate significantly from their behavior in mixed cultures, a feature that reflects a limited capacity of such assays to generate insights into physiological and pathological conditions. Reciprocal influences between effector and regulatory cells are also influenced by other cell types and involve both soluble factors and cell-to-cell interactions. In addition to IL-2 as a dominant cytokine in function of Treg, TCR-associated stimulation and co-stimulation have the capacity to modulate the sensitivity of T cells to apoptosis. Variations in cell death affect the Teff:Treg ratios and consequently impact the severity of inflammatory insulitis in the murine model of type 1 diabetes. Importantly, the data presented here question the validity of the contention that polarized sensitivity to apoptosis measured in isolated subsets underlie the dominance of diabetogenic clones in NOD mice and human diabetics.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Mice</title><p>Mice used in this study were C57BL/6 and non obese diabetic (NOD) purchased from Jackson Laboratories (Bar Harbor, ME). The inbred colonies were housed in a barrier facility. The Institutional Animal Care Committee of the Schneider Medical Center has approved all procedures #022B6229 dated 4.1.2009. Blood glucose was monitored between 9&#x02013;11 AM in tail blood samples at weekly intervals using a glucometer (Accu-Chek Sensor, Roche Diagnostics, USA). Diabetes was defined as two consecutive blood glucose measurements above 200 mg/dl.</p></sec><sec id="s4b"><title>Cell preparation</title><p>Spleens and lymph nodes were harvested and gently minced on a 40 &#x000b5;M nylon mesh in HBSS (Kibbutz Beit Haemek, Israel) to prepare single cell suspensions. Lymphocytes were enriched by centrifugation over 1.5 ml Lympholyte-M (Cedarlane, Ontario, Canada) and T cells were collected after immunomagnetic depletion using antibodies against MAC-1, GR-1. NK1.1 and B220 <xref ref-type="bibr" rid="pone.0015684-PearlYafe2">&#x0005b;61&#x0005d;</xref>. All antibodies were obtained from hybridoma cell cultures (ATCC). Antibody-coated cells were washed twice with PBS containing 2&#x00025; FCS and were incubated with sheep-anti-rat IgG conjugated to M-450 magnetic beads at a ratio of 4&#x02013;5 beads per cell (Dynal Inc.). Conjugated cells were precipitated by exposure to a magnetic field. The purity of T cell elution was reassessed by flow cytometry using primary labeled monoclonal antibodies against CD4 and CD8. For flow cytometry the red cells were removed by ammonium chloride lysis for 4 minutes at room temperature. The reaction was arrested with excess ice-cold solution and cells were washed.</p></sec><sec id="s4c"><title>Isolation of cells according to CD25 expression</title><p>CD25<sup>&#x02212;</sup> and CD25<sup>&#x0002b;</sup> subsets of CD4<sup>&#x0002b;</sup> T cells are isolated from the spleens and mesenteric lymph nodes using the CD4<sup>&#x0002b;</sup>CD25<sup>&#x0002b;</sup> Regulatory T cell isolation kit (Miltenyi Biotec, Bergisch-Gladbach, Germany) <xref ref-type="bibr" rid="pone.0015684-Yarkoni2">&#x0005b;62&#x0005d;</xref>. In first stage lymphocytes were mixed with a cocktail of biotinylated antibodies against CD8, CD11b, CD45R, CD49b and Ter-119 and incubated with magnetic beads conjugated to anti-biotin antibody. Elution through a column under a magnetic field enriched the unlabeled CD4<sup>&#x0002b;</sup> T cells. In second stage CD25<sup>&#x0002b;</sup> was stained with PE-labeled monoclonal antibodies, mixed with anti-PE magnetic microbeads and positively selected by passage through a second column under a magnetic field. Purity was evaluated using FITC-labeled monoclonal antibodies. Immunomagnetic isolation of cells from NOD females yields a CD4<sup>&#x0002b;</sup>CD25<sup>&#x02212;</sup> subset contaminated with 0.7&#x000b1;0.4&#x00025; and 3.6&#x000b1;1.3&#x00025; CD25<sup>&#x0002b;</sup> and FoxP3<sup>&#x0002b;</sup> cells respectively, and a CD4<sup>&#x0002b;</sup>CD25<sup>&#x0002b;</sup> subset of which 75&#x000b1;4&#x00025; expressed FoxP3, and are contaminated with 17&#x000b1;8&#x00025; CD25<sup>&#x02212;/low</sup> cells.</p></sec><sec id="s4d"><title>Flow cytometry</title><p>Cells were labeled by incubation for 45 minutes at 4&#x000b0;C with the appropriate antibodies conjugated to fluorescein isothyocyanate (FITC), phycoerythrin (PE), allophycocyanin (APC) and peridinin chlorophyll a-protein (PerCP, BD Pharmingen, San Diego, CA): CD4 (clone RM 4&#x02013;5), CD8 (clone 53-6.7), CD25 (clone PC61.5) <xref ref-type="bibr" rid="pone.0015684-PearlYafe2">&#x0005b;61&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0015684-Yarkoni2">&#x0005b;62&#x0005d;</xref>. Cells were washed in PBS, incubated for 45 min at 4&#x000b0;C with labeled primary mAb or counterstained with a fluorochrome-labeled secondary mAb. FoxP3 was determined following permeabilization and intracellular staining with a PE-labeled antibody (Foxp3 staining buffer set NRRF-30, eBioscience, San Diego, CA). Antibodies were purchased from BD Pharmingen and eBioscience. Cell death and apoptosis were determined in cells incubated with 5 &#x000b5;g/ml 7-aminoactinomycin-D (7-AAD, Sigma, St. Lois, MO) and Annexin-V (IQ products, Groningen, The Netherlands). Measurements were performed with a Vantage SE flow cytometer (Becton Dickinson, Franklin Lakes, NJ). Positive staining was determined on a log scale, normalized with control cells stained with isotype control antibodies.</p></sec><sec id="s4e"><title>In vitro apoptosis</title><p>A concentration of 2&#x000d7;10<sup>6</sup> cells/ml was prepared in DMEM supplemented with 2 mM L-glutamine, 1 mM sodium pyruvate, 13.6 &#x000b5;M folic acid, 270 &#x000b5;M L-asparagine, 548 &#x000b5;M L-arginine HCL, 10 mM HEPES, 50 &#x000b5;M 2&#x003b2;-Mercaptoethanol, 100 mg/ml streptomycin, 100 U/ml penicillin and 5&#x00025; heat-inactivated fetal bovine serum (FBS) (MLR medium) <xref ref-type="bibr" rid="pone.0015684-PearlYafe2">&#x0005b;61&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0015684-Kaminitz1">&#x0005b;63&#x0005d;</xref>. All ingredients were purchased from Beit Haemek and Sigma (St. Lois, MO). Cells were stimulated by exogenous supplementation of 2000 U/ml IL-2 (Peprotech, London, UK), and beads conjugated to anti-CD3 and anti-CD28 (Invitrogen, Oslo, Norway) at a bead:cell ratio of 1&#x02236;1. For determination of apoptosis in reference to FoxP3 expression, cells were first exposed to Annexin-V and subsequently were stained for FoxP3 expression.</p></sec><sec id="s4f"><title>Proliferation assay</title><p>Splenocytes and lymphocytes were incubated at room temperature for 7 minutes with 10 &#x000b5;M 5-(and 6-)-carboxyfluorescein diacetate succinimidyl ester (CFSE, Molecular Probes, Carlsbad, CA), and uptake was arrested by addition of 50&#x00025; FCS. Stained cells were washed with PBS and cultured at 37&#x000b0;C in a humidified 5&#x00025; CO<sub>2</sub> atmosphere for 3 days in MLR medium containing 1&#x00025; heat-inactivated mouse serum <xref ref-type="bibr" rid="pone.0015684-Kaminitz1">&#x0005b;63&#x0005d;</xref>. Cells were stimulated with 5 &#x000b5;M concanavalin A (ConA, Sigma) and isolated CD25<sup>&#x0002b;</sup> T cells were incubated with 20 U/ml IL-2. All proliferation assays were performed in triplicates. Suppression of T cell proliferation was performed in stimulated mixed cultures. Isolated target CD4<sup>&#x0002b;</sup>CD25<sup>&#x02212;</sup> T cells were labeled with CFSE and stimulated with an equal number of CD3/CD28 beads. Proliferation was assessed after 48 hours with and without the addition of CD4<sup>&#x0002b;</sup>CD25<sup>&#x0002b;</sup> T cells at various ratios. CFSE dilution was analyzed in flow cytometry by gating on the live lymphocytes and proliferation was quantified the ModFit software (Verity Software House, Topsham, ME).</p></sec><sec id="s4g"><title>Statistical analysis</title><p>Data are presented as means &#x000b1; standard deviations for each experimental protocol. Results in each experimental group were evaluated for reproducibility by linear regression of duplicate measurements. Differences between the experimental protocols were estimated with a post hoc Scheffe <italic>t</italic>-test and significance was considered at p&#x0003c;0.05.</p></sec></sec></body><back><ack><p>The major contribution and support of Moshe Philip, Endocrinology Institute, Schneider Children's Medical Center of Israel, is gratefully acknowledged. We thank the excellent technical assistance of Mrs. Ela Zuzovsky and Mrs. Ana Zemlianski.</p><p>This study is part of the PhD thesis of Ayelet Kaminitz.</p></ack><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This study was supported by a generous grant from the Leah and Edward M. Frankel Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group><ref-list><title>References</title><ref id="pone.0015684-Shevach1"><label>1</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Shevach</surname><given-names>EM</given-names></name></person-group>             <year>2000</year>             <article-title>Regulatory T cells in autoimmmunity.</article-title>             <source>Annu Rev Immunol</source>             <volume>18</volume>             <fpage>423</fpage>             <lpage>449</lpage>          <pub-id pub-id-type="pmid">10837065</pub-id></mixed-citation></ref><ref id="pone.0015684-Maloy1"><label>2</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Maloy</surname><given-names>KJ</given-names></name><name><surname>Powrie</surname><given-names>F</given-names></name></person-group>             <year>2001</year>             <article-title>Regulatory T cells in the control of immune pathology.</article-title>             <source>Nat Immunol</source>             <volume>2</volume>             <fpage>816</fpage>             <lpage>822</lpage>          <pub-id pub-id-type="pmid">11526392</pub-id></mixed-citation></ref><ref id="pone.0015684-Bluestone1"><label>3</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Bluestone</surname><given-names>JA</given-names></name><name><surname>Abbas</surname><given-names>AK</given-names></name></person-group>             <year>2003</year>             <article-title>Natural versus adaptive regulatory T cells.</article-title>             <source>Nat Rev Immunol</source>             <volume>3</volume>             <fpage>253</fpage>             <lpage>257</lpage>          <pub-id pub-id-type="pmid">12658273</pub-id></mixed-citation></ref><ref id="pone.0015684-Sakaguchi1"><label>4</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Sakaguchi</surname><given-names>S</given-names></name></person-group>             <year>2004</year>             <article-title>Naturally arising CD4&#x0002b; regulatory T cells for immunologic self-tolerance and negative control of immune responses.</article-title>             <source>Annu Rev Immunol</source>             <volume>22</volume>             <fpage>531</fpage>             <lpage>562</lpage>          <pub-id pub-id-type="pmid">15032588</pub-id></mixed-citation></ref><ref id="pone.0015684-Sakaguchi2"><label>5</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Sakaguchi</surname><given-names>S</given-names></name><name><surname>Sakaguchi</surname><given-names>N</given-names></name><name><surname>Asano</surname><given-names>M</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name><name><surname>Toda</surname><given-names>M</given-names></name></person-group>             <year>1995</year>             <article-title>Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor &#x003b1;-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.</article-title>             <source>J Immunol</source>             <volume>155</volume>             <fpage>1151</fpage>             <lpage>1164</lpage>          <pub-id pub-id-type="pmid">7636184</pub-id></mixed-citation></ref><ref id="pone.0015684-Hori1"><label>6</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Hori</surname><given-names>S</given-names></name><name><surname>Nomura</surname><given-names>T</given-names></name><name><surname>Sakaguchi</surname><given-names>S</given-names></name></person-group>             <year>2003</year>             <article-title>Control of regulatory T cell development by the transcription factor Foxp3.</article-title>             <source>Science</source>             <volume>299</volume>             <fpage>1057</fpage>             <lpage>1106</lpage>          <pub-id pub-id-type="pmid">12522256</pub-id></mixed-citation></ref><ref id="pone.0015684-Herbelin1"><label>7</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Herbelin</surname><given-names>A</given-names></name><name><surname>Gombert</surname><given-names>JM</given-names></name><name><surname>Lepault</surname><given-names>F</given-names></name><name><surname>Bach</surname><given-names>JF</given-names></name><name><surname>Chatenoud</surname><given-names>L</given-names></name></person-group>             <year>1998</year>             <article-title>Mature mainstream TCR alpha beta<sup>&#x0002b;</sup> CD4<sup>&#x0002b;</sup> thymocytes expressing l-selectin mediate &#x0201c;active tolerance&#x0201d; in the nonobese diabetic mouse.</article-title>             <source>J Immunol</source>             <volume>161</volume>             <fpage>2620</fpage>             <lpage>2628</lpage>          <pub-id pub-id-type="pmid">9725264</pub-id></mixed-citation></ref><ref id="pone.0015684-Lepault1"><label>8</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Lepault</surname><given-names>F</given-names></name><name><surname>Gagnerault</surname><given-names>MC</given-names></name></person-group>             <year>2000</year>             <article-title>Characterization of peripheral regulatory CD4<sup>&#x0002b;</sup> T cells that prevent diabetes onset in nonobese diabetic mice.</article-title>             <source>J Immunol</source>             <volume>164</volume>             <fpage>240</fpage>             <lpage>247</lpage>          <pub-id pub-id-type="pmid">10605017</pub-id></mixed-citation></ref><ref id="pone.0015684-Salomon1"><label>9</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Salomon</surname><given-names>B</given-names></name><name><surname>Lenschow</surname><given-names>DJ</given-names></name><name><surname>Rhee</surname><given-names>L</given-names></name><name><surname>Ashourian</surname><given-names>N</given-names></name><name><surname>Singh</surname><given-names>B</given-names></name><etal/></person-group>             <year>2000</year>             <article-title>B7/CD28 co-stimulation is essential for the homeostasis of the CD4<sup>&#x0002b;</sup>CD25<sup>&#x0002b;</sup> immunoregulatory T cells that control autoimmune diabetes.</article-title>             <source>Immunity</source>             <volume>12</volume>             <fpage>431</fpage>             <lpage>440</lpage>          <pub-id pub-id-type="pmid">10795741</pub-id></mixed-citation></ref><ref id="pone.0015684-vonBoehmer1"><label>10</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>von Boehmer</surname><given-names>H</given-names></name></person-group>             <year>2005</year>             <article-title>Mechanisms of suppression by suppressor T cells.</article-title>             <source>Nat Immunol</source>             <volume>6</volume>             <fpage>338</fpage>             <lpage>344</lpage>          <pub-id pub-id-type="pmid">15785759</pub-id></mixed-citation></ref><ref id="pone.0015684-Miyara1"><label>11</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Miyara</surname><given-names>M</given-names></name><name><surname>Sakaguchi</surname><given-names>S</given-names></name></person-group>             <year>2007</year>             <article-title>Natural regulatory T cells: mechanisms of suppression.</article-title>             <source>Trends Mol Med</source>             <volume>13</volume>             <fpage>108</fpage>             <lpage>116</lpage>          <pub-id pub-id-type="pmid">17257897</pub-id></mixed-citation></ref><ref id="pone.0015684-Askenasy1"><label>12</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Askenasy</surname><given-names>N</given-names></name><name><surname>Kaminitz</surname><given-names>A</given-names></name><name><surname>Yarkoni</surname><given-names>S</given-names></name></person-group>             <year>2008</year>             <article-title>Mechanisms of T regulatory cell function.</article-title>             <source>Autoimmun Rev</source>             <volume>7</volume>             <fpage>370</fpage>             <lpage>375</lpage>          <pub-id pub-id-type="pmid">18486924</pub-id></mixed-citation></ref><ref id="pone.0015684-Colucci1"><label>13</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Colucci</surname><given-names>F</given-names></name><name><surname>Cilio</surname><given-names>C</given-names></name><name><surname>Leijon</surname><given-names>K</given-names></name><name><surname>Penha Goncalves</surname><given-names>C</given-names></name><name><surname>Bergman</surname><given-names>ML</given-names></name><etal/></person-group>             <year>1996</year>             <article-title>Programmed cell death in the pathogenesis of murine IDDM: resistance to apoptosis induced in lymphocytes by cyclophosphamide.</article-title>             <source>J Autoimmun</source>             <volume>9</volume>             <fpage>271</fpage>             <lpage>276</lpage>          <pub-id pub-id-type="pmid">8738973</pub-id></mixed-citation></ref><ref id="pone.0015684-Radosevic1"><label>14</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Radosevic</surname><given-names>K</given-names></name><name><surname>Casteels</surname><given-names>KM</given-names></name><name><surname>Mathieu</surname><given-names>C</given-names></name><name><surname>van Ewijk</surname><given-names>W</given-names></name><name><surname>Drexhage</surname><given-names>H</given-names></name><etal/></person-group>             <year>1999</year>             <article-title>Splenic dendritic cells from the nonobese diabetic mouse induce a prolonged proliferation of syngeneic T cells. A role for an impaired apoptosis of NOD T cells?</article-title>             <source>J Autoimmun</source>             <volume>13</volume>             <fpage>373</fpage>             <lpage>382</lpage>          <pub-id pub-id-type="pmid">10585753</pub-id></mixed-citation></ref><ref id="pone.0015684-Arreaza1"><label>15</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Arreaza</surname><given-names>G</given-names></name><name><surname>Salojin</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Gill</surname><given-names>B</given-names></name><etal/></person-group>             <year>2003</year>             <article-title>Deficient activation and resistance to activation-induced apoptosis of CD8&#x0002b; T cells is associated with defective peripheral tolerance in nonobese diabetic mice.</article-title>             <source>Clin Immunol</source>             <volume>107</volume>             <fpage>103</fpage>             <lpage>115</lpage>          <pub-id pub-id-type="pmid">12763479</pub-id></mixed-citation></ref><ref id="pone.0015684-Decallonne1"><label>16</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Decallonne</surname><given-names>B</given-names></name><name><surname>van Etten</surname><given-names>E</given-names></name><name><surname>Giulietti</surname><given-names>A</given-names></name><name><surname>Casteels</surname><given-names>K</given-names></name><name><surname>Overbergh</surname><given-names>L</given-names></name><etal/></person-group>             <year>2003</year>             <article-title>Defect in activation induced cell death in non-obese diabetic (NOD) T lymphocytes.</article-title>             <source>J Autoimmun</source>             <volume>20</volume>             <fpage>219</fpage>             <lpage>226</lpage>          <pub-id pub-id-type="pmid">12753807</pub-id></mixed-citation></ref><ref id="pone.0015684-Yolcu1"><label>17</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Yolcu</surname><given-names>ES</given-names></name><name><surname>Kaminitz</surname><given-names>A</given-names></name><name><surname>Ash</surname><given-names>S</given-names></name><name><surname>Sagiv</surname><given-names>Y</given-names></name><name><surname>Askenasy</surname><given-names>N</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Apoptosis as a mechanism of T regulatory cell homeostasis and suppression.</article-title>             <source>Immunol Cell Biol</source>             <volume>86</volume>             <fpage>650</fpage>             <lpage>658</lpage>          <pub-id pub-id-type="pmid">18794907</pub-id></mixed-citation></ref><ref id="pone.0015684-Taams1"><label>18</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Taams</surname><given-names>LS</given-names></name><name><surname>Smfith</surname><given-names>J</given-names></name><name><surname>Rustin</surname><given-names>MH</given-names></name><name><surname>Salmon</surname><given-names>M</given-names></name><name><surname>Poulter</surname><given-names>LW</given-names></name><etal/></person-group>             <year>2001</year>             <article-title>Human anergic/suppressive CD4(&#x0002b;)CD25(&#x0002b;) T cells: a highly differentiated and apoptosis-prone population.</article-title>             <source>Eur J Immunol</source>             <volume>31</volume>             <fpage>1122</fpage>             <lpage>1131</lpage>          <pub-id pub-id-type="pmid">11298337</pub-id></mixed-citation></ref><ref id="pone.0015684-Fritzsching1"><label>19</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Fritzsching</surname><given-names>B</given-names></name><name><surname>Oberle</surname><given-names>N</given-names></name><name><surname>Eberhardt</surname><given-names>N</given-names></name><name><surname>Quick</surname><given-names>S</given-names></name><name><surname>Haas</surname><given-names>J</given-names></name><etal/></person-group>             <year>2005</year>             <article-title>In contrast to effector T cells, CD4&#x0002b;CD25&#x0002b;FoxP3&#x0002b; regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death.</article-title>             <source>J Immunol</source>             <volume>175</volume>             <fpage>32</fpage>             <lpage>36</lpage>          <pub-id pub-id-type="pmid">15972628</pub-id></mixed-citation></ref><ref id="pone.0015684-GlisicMilosavljevic1"><label>20</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Glisic-Milosavljevic</surname><given-names>S</given-names></name><name><surname>Waukau</surname><given-names>J</given-names></name><name><surname>Jailwala</surname><given-names>P</given-names></name><name><surname>Jana</surname><given-names>S</given-names></name><name><surname>Khoo</surname><given-names>HJ</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4&#x0002b;CD25&#x0002b; T-cell fraction.</article-title>             <source>PLoS ONE</source>             <volume>2</volume>             <fpage>e146</fpage>          <pub-id pub-id-type="pmid">17206281</pub-id></mixed-citation></ref><ref id="pone.0015684-Jailwala1"><label>21</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Jailwala</surname><given-names>P</given-names></name><name><surname>Waukau</surname><given-names>J</given-names></name><name><surname>Glisic</surname><given-names>S</given-names></name><name><surname>Jana</surname><given-names>S</given-names></name><name><surname>Ehlenbach</surname><given-names>S</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Apoptosis of CD4<sup>&#x0002b;</sup>CD25<sup>high</sup> T Cells in Type 1 Diabetes may be partially mediated by IL-2 deprivation.</article-title>             <source>PLoS ONE</source>             <volume>4</volume>             <fpage>e6527</fpage>          <pub-id pub-id-type="pmid">19654878</pub-id></mixed-citation></ref><ref id="pone.0015684-Kukreja1"><label>22</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Kukreja</surname><given-names>A</given-names></name><name><surname>Cost</surname><given-names>G</given-names></name><name><surname>Marker</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><etal/></person-group>             <year>2002</year>             <article-title>Multiple immunoregulatory defects in type-1 diabetes.</article-title>             <source>J Clin Invest</source>             <volume>109</volume>             <fpage>131</fpage>             <lpage>140</lpage>          <pub-id pub-id-type="pmid">11781358</pub-id></mixed-citation></ref><ref id="pone.0015684-Lindley1"><label>23</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Lindley</surname><given-names>S</given-names></name><name><surname>Dayan</surname><given-names>CM</given-names></name><name><surname>Bishop</surname><given-names>A</given-names></name><name><surname>Roep</surname><given-names>BO</given-names></name><name><surname>Peakman</surname><given-names>M</given-names></name><etal/></person-group>             <year>2005</year>             <article-title>Defective suppressor function in CD4(&#x0002b;)CD25(&#x0002b;) T-cells from patients with type 1 diabetes.</article-title>             <source>Diabetes</source>             <volume>54</volume>             <fpage>92</fpage>             <lpage>99</lpage>          <pub-id pub-id-type="pmid">15616015</pub-id></mixed-citation></ref><ref id="pone.0015684-Brusko1"><label>24</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Brusko</surname><given-names>TM</given-names></name><name><surname>Wasserfall</surname><given-names>CH</given-names></name><name><surname>Clare-Salzler</surname><given-names>MJ</given-names></name><name><surname>Schatz</surname><given-names>DA</given-names></name><name><surname>Atkinson</surname><given-names>MA</given-names></name></person-group>             <year>2005</year>             <article-title>Functional defects and the influence of age on the frequency of CD4&#x0002b; CD25&#x0002b; Tcells in type 1 diabetes.</article-title>             <source>Diabetes</source>             <volume>54</volume>             <fpage>1407</fpage>             <lpage>1414</lpage>          <pub-id pub-id-type="pmid">15855327</pub-id></mixed-citation></ref><ref id="pone.0015684-Putnam1"><label>25</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Putnam</surname><given-names>AL</given-names></name><name><surname>Vendrame</surname><given-names>F</given-names></name><name><surname>Dotta</surname><given-names>F</given-names></name><name><surname>Gottlieb</surname><given-names>PA</given-names></name></person-group>             <year>2005</year>             <article-title>CD4&#x0002b;CD25high regulatory T cells in human autoimmune diabetes.</article-title>             <source>J Autoimmun</source>             <volume>24</volume>             <fpage>55</fpage>             <lpage>62</lpage>          <pub-id pub-id-type="pmid">15725577</pub-id></mixed-citation></ref><ref id="pone.0015684-You1"><label>26</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>You</surname><given-names>S</given-names></name><name><surname>Belghith</surname><given-names>M</given-names></name><name><surname>Cobbold</surname><given-names>S</given-names></name><name><surname>Alyanakian</surname><given-names>MA</given-names></name><name><surname>Gouarin</surname><given-names>C</given-names></name><etal/></person-group>             <year>2005</year>             <article-title>Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells.</article-title>             <source>Diabetes</source>             <volume>54</volume>             <fpage>1415</fpage>             <lpage>1422</lpage>          <pub-id pub-id-type="pmid">15855328</pub-id></mixed-citation></ref><ref id="pone.0015684-Mellanby1"><label>27</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Mellanby</surname><given-names>RJ</given-names></name><name><surname>Thomas</surname><given-names>D</given-names></name><name><surname>Phillips</surname><given-names>JM</given-names></name><name><surname>Cooke</surname><given-names>A</given-names></name></person-group>             <year>2007</year>             <article-title>Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4&#x0002b; CD25&#x0002b; Foxp3&#x0002b; regulatory T cells.</article-title>             <source>Immunology</source>             <volume>121</volume>             <fpage>15</fpage>             <lpage>28</lpage>          <pub-id pub-id-type="pmid">17428252</pub-id></mixed-citation></ref><ref id="pone.0015684-Mohamood1"><label>28</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Mohamood</surname><given-names>AS</given-names></name><name><surname>Trujillo</surname><given-names>CJ</given-names></name><name><surname>Zheng</surname><given-names>D</given-names></name><name><surname>Jie</surname><given-names>C</given-names></name><name><surname>Murillo</surname><given-names>FM</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Gld mutation of Fas ligand increases the frequency and up-regulates cell survival genes in CD25<sup>&#x0002b;</sup>CD4<sup>&#x0002b;</sup> TR cells.</article-title>             <source>Int Immunol</source>             <volume>18</volume>             <fpage>1265</fpage>             <lpage>1277</lpage>          <pub-id pub-id-type="pmid">16769751</pub-id></mixed-citation></ref><ref id="pone.0015684-Kuniyasu1"><label>29</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Kuniyasu</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name><name><surname>Shimizu</surname><given-names>J</given-names></name><name><surname>Toda</surname><given-names>G</given-names></name><etal/></person-group>             <year>2000</year>             <article-title>Naturally anergic and suppressive CD25<sup>&#x0002b;</sup>CD4<sup>&#x0002b;</sup> T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation.</article-title>             <source>Int Immunol</source>             <volume>12</volume>             <fpage>1145</fpage>             <lpage>1155</lpage>          <pub-id pub-id-type="pmid">10917889</pub-id></mixed-citation></ref><ref id="pone.0015684-Gavin1"><label>30</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Gavin</surname><given-names>MA</given-names></name><name><surname>Clarke</surname><given-names>SR</given-names></name><name><surname>Negrou</surname><given-names>E</given-names></name><name><surname>Gallegos</surname><given-names>A</given-names></name><name><surname>Rudensky</surname><given-names>A</given-names></name></person-group>             <year>2002</year>             <article-title>Homeostasis and anergy of CD4(&#x0002b;)CD25(&#x0002b;) suppressor T cells in vivo.</article-title>             <source>Nat Immunol</source>             <volume>3</volume>             <fpage>33</fpage>             <lpage>41</lpage>          <pub-id pub-id-type="pmid">11740498</pub-id></mixed-citation></ref><ref id="pone.0015684-Fisson1"><label>31</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Fisson</surname><given-names>S</given-names></name><name><surname>Darrasse-Jeze</surname><given-names>G</given-names></name><name><surname>Litvinova</surname><given-names>E</given-names></name><name><surname>Septier</surname><given-names>F</given-names></name><name><surname>Klatzmann</surname><given-names>D</given-names></name><etal/></person-group>             <year>2003</year>             <article-title>Continuous activation of autoreactive CD4&#x0002b; CD25&#x0002b; regulatory T cells in the steady state.</article-title>             <source>J Exp Med</source>             <volume>198</volume>             <fpage>737</fpage>             <lpage>746</lpage>          <pub-id pub-id-type="pmid">12939344</pub-id></mixed-citation></ref><ref id="pone.0015684-Askenasy2"><label>32</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Askenasy</surname><given-names>N</given-names></name><name><surname>Yolcu</surname><given-names>ES</given-names></name><name><surname>Shirwan</surname><given-names>H</given-names></name><name><surname>Stein</surname><given-names>J</given-names></name><name><surname>Yaniv</surname><given-names>I</given-names></name><etal/></person-group>             <year>2003</year>             <article-title>Characterization of adhesion and viability of early seeding hematopoietic cells in the host bone marrow in vivo and in situ.</article-title>             <source>Exp Hematol</source>             <volume>31</volume>             <fpage>1292</fpage>             <lpage>300</lpage>          <pub-id pub-id-type="pmid">14662337</pub-id></mixed-citation></ref><ref id="pone.0015684-Banz1"><label>33</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Banz</surname><given-names>A</given-names></name><name><surname>Pontoux</surname><given-names>C</given-names></name><name><surname>Papiernik</surname><given-names>M</given-names></name></person-group>             <year>2002</year>             <article-title>Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells.</article-title>             <source>J Immunol</source>             <volume>169</volume>             <fpage>750</fpage>             <lpage>757</lpage>          <pub-id pub-id-type="pmid">12097377</pub-id></mixed-citation></ref><ref id="pone.0015684-DAlise1"><label>34</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>D"Alise</surname><given-names>AM</given-names></name><name><surname>Auyeung</surname><given-names>V</given-names></name><name><surname>Feuerer</surname><given-names>M</given-names></name><name><surname>Nishio</surname><given-names>J</given-names></name><name><surname>Fontenot</surname><given-names>J</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors.</article-title>             <source>Proc Natl Acad Sci USA</source>             <volume>105</volume>             <fpage>19857</fpage>             <lpage>19862</lpage>          <pub-id pub-id-type="pmid">19073938</pub-id></mixed-citation></ref><ref id="pone.0015684-Lenardo1"><label>35</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Lenardo</surname><given-names>MJ</given-names></name></person-group>             <year>1991</year>             <article-title>Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis.</article-title>             <source>Nature</source>             <volume>353</volume>             <fpage>858</fpage>             <lpage>861</lpage>          <pub-id pub-id-type="pmid">1944559</pub-id></mixed-citation></ref><ref id="pone.0015684-Pandiyan1"><label>36</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Pandiyan</surname><given-names>P</given-names></name><name><surname>Lenardo</surname><given-names>MJ</given-names></name></person-group>             <year>2008</year>             <article-title>The control of CD4&#x0002b;CD25&#x0002b;Foxp3&#x0002b; regulatory T cell survival.</article-title>             <source>Biol Direct</source>             <volume>3</volume>             <fpage>6</fpage>          <pub-id pub-id-type="pmid">18304352</pub-id></mixed-citation></ref><ref id="pone.0015684-Yarkoni1"><label>37</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Yarkoni</surname><given-names>S</given-names></name><name><surname>Kaminitz</surname><given-names>A</given-names></name><name><surname>Sagiv</surname><given-names>Y</given-names></name><name><surname>Yaniv</surname><given-names>I</given-names></name><name><surname>Askenasy</surname><given-names>N</given-names></name></person-group>             <year>2008</year>             <article-title>Involvement of IL-2 in homeostasis of regulatory T cells: the IL-2 cycle.</article-title>             <source>BioEssays</source>             <volume>30</volume>             <fpage>875</fpage>             <lpage>888</lpage>          <pub-id pub-id-type="pmid">18693266</pub-id></mixed-citation></ref><ref id="pone.0015684-Takahashi1"><label>38</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Kuniyasu</surname><given-names>Y</given-names></name><name><surname>Toda</surname><given-names>M</given-names></name><name><surname>Sakaguchi</surname><given-names>N</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name><etal/></person-group>             <year>1998</year>             <article-title>Immunologic self-tolerance maintained by CD25<sup>&#x0002b;</sup>CD4<sup>&#x0002b;</sup> naturally anergic and suppressive T cells.</article-title>             <source>Int Immunol</source>             <volume>10</volume>             <fpage>1969</fpage>             <lpage>1980</lpage>          <pub-id pub-id-type="pmid">9885918</pub-id></mixed-citation></ref><ref id="pone.0015684-Thornton1"><label>39</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Thornton</surname><given-names>AM</given-names></name><name><surname>Shevach</surname><given-names>EM</given-names></name></person-group>             <year>1998</year>             <article-title>CD4<sup>&#x0002b;</sup>CD25<sup>&#x0002b;</sup> immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.</article-title>             <source>J Exp Med</source>             <volume>188</volume>             <fpage>287</fpage>             <lpage>296</lpage>          <pub-id pub-id-type="pmid">9670041</pub-id></mixed-citation></ref><ref id="pone.0015684-Tang1"><label>40</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Tang</surname><given-names>Q</given-names></name><name><surname>Henriksen</surname><given-names>KJ</given-names></name><name><surname>Bi</surname><given-names>M</given-names></name><name><surname>Finger</surname><given-names>EB</given-names></name><name><surname>Szot</surname><given-names>G</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes.</article-title>             <source>J Exp Med</source>             <volume>199</volume>             <fpage>1455</fpage>             <lpage>1465</lpage>          <pub-id pub-id-type="pmid">15184499</pub-id></mixed-citation></ref><ref id="pone.0015684-Askenasy3"><label>41</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Askenasy</surname><given-names>N</given-names></name><name><surname>Farkas</surname><given-names>DL</given-names></name></person-group>             <year>2002</year>             <article-title>Optical imaging of PKH-labeled hematopoietic cells in recipient bone marrow <italic>in vivo</italic>.</article-title>             <source>Stem Cells</source>             <volume>20</volume>             <fpage>501</fpage>             <lpage>513</lpage>          <pub-id pub-id-type="pmid">12456958</pub-id></mixed-citation></ref><ref id="pone.0015684-Yolcu2"><label>42</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Yolcu</surname><given-names>ES</given-names></name><name><surname>Askenasy</surname><given-names>N</given-names></name><name><surname>Singh</surname><given-names>NP</given-names></name><name><surname>Cherradi</surname><given-names>SE</given-names></name><name><surname>Shirwan</surname><given-names>H</given-names></name></person-group>             <year>2002</year>             <article-title>Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection.</article-title>             <source>Immunity</source>             <volume>17</volume>             <fpage>795</fpage>             <lpage>808</lpage>          <pub-id pub-id-type="pmid">12479825</pub-id></mixed-citation></ref><ref id="pone.0015684-Jiang1"><label>43</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Jiang</surname><given-names>N</given-names></name><name><surname>Reich</surname><given-names>CF</given-names><suffix>3rd</suffix></name><name><surname>Pisetsky</surname><given-names>DS</given-names></name></person-group>             <year>2003</year>             <article-title>Role of macrophages in the generation of circulating blood nucleosomes from dead and dying cells.</article-title>             <source>Blood</source>             <volume>102</volume>             <fpage>2243</fpage>             <lpage>2250</lpage>          <pub-id pub-id-type="pmid">12775567</pub-id></mixed-citation></ref><ref id="pone.0015684-Asquith1"><label>44</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Asquith</surname><given-names>B</given-names></name><name><surname>Borghans</surname><given-names>JA</given-names></name><name><surname>Ganusov</surname><given-names>VV</given-names></name><name><surname>Macallan</surname><given-names>DC</given-names></name></person-group>             <year>2009</year>             <article-title>Lymphocyte kinetics in health and disease.</article-title>             <source>Trends Immunol</source>             <volume>30</volume>             <fpage>182</fpage>             <lpage>189</lpage>          <pub-id pub-id-type="pmid">19286425</pub-id></mixed-citation></ref><ref id="pone.0015684-GlisicMilosavljevic2"><label>45</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Glisic-Milosavljevic</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Koppen</surname><given-names>M</given-names></name><name><surname>Kramer</surname><given-names>J</given-names></name><name><surname>Ehlenbach</surname><given-names>S</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>Dynamic changes in CD4&#x0002b; CD25&#x0002b;(high) T cell apoptosis after the diagnosis of type 1 diabetes.</article-title>             <source>Clin Exp Immunol</source>             <volume>150</volume>             <fpage>75</fpage>             <lpage>82</lpage>          <pub-id pub-id-type="pmid">17711492</pub-id></mixed-citation></ref><ref id="pone.0015684-Klein1"><label>46</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Klein</surname><given-names>L</given-names></name><name><surname>Khazaie</surname><given-names>K</given-names></name><name><surname>von Boehmer</surname><given-names>H</given-names></name></person-group>             <year>2003</year>             <article-title>In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior <italic>in vitro</italic>.</article-title>             <source>Proc Natl Acad Sci USA</source>             <volume>100</volume>             <fpage>8886</fpage>             <lpage>8891</lpage>          <pub-id pub-id-type="pmid">12857946</pub-id></mixed-citation></ref><ref id="pone.0015684-Schneider1"><label>47</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Schneider</surname><given-names>A</given-names></name><name><surname>Rieck</surname><given-names>M</given-names></name><name><surname>Sanda</surname><given-names>S</given-names></name><name><surname>Pihoker</surname><given-names>C</given-names></name><name><surname>Greenbaum</surname><given-names>C</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>The effector T cells of diabetic subjects are resistant to regulation via CD4&#x0002b; FOXP3&#x0002b; regulatory T cells.</article-title>             <source>J Immunol</source>             <volume>181</volume>             <fpage>7350</fpage>             <lpage>7355</lpage>          <pub-id pub-id-type="pmid">18981158</pub-id></mixed-citation></ref><ref id="pone.0015684-Chen1"><label>48</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Herman</surname><given-names>AE</given-names></name><name><surname>Matos</surname><given-names>M</given-names></name><name><surname>Mathis</surname><given-names>D</given-names></name><name><surname>Benoist</surname><given-names>C</given-names></name></person-group>             <year>2005</year>             <article-title>Where CD4<sup>&#x0002b;</sup>CD25<sup>&#x0002b;</sup> T reg cells impinge on autoimmune diabetes.</article-title>             <source>J Exp Med</source>             <volume>202</volume>             <fpage>1387</fpage>             <lpage>1397</lpage>          <pub-id pub-id-type="pmid">16301745</pub-id></mixed-citation></ref><ref id="pone.0015684-PearlYafe1"><label>49</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Pearl-Yafe</surname><given-names>M</given-names></name><name><surname>Iskovich</surname><given-names>S</given-names></name><name><surname>Kaminitz</surname><given-names>A</given-names></name><name><surname>Stein</surname><given-names>J</given-names></name><name><surname>Yaniv</surname><given-names>I</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Does physiological &#x003b2; cell turnover initiate autoimmune diabetes in the regional lymph nodes?</article-title>             <source>Autoimmun Rev</source>             <volume>5</volume>             <fpage>338</fpage>             <lpage>343</lpage>          <pub-id pub-id-type="pmid">16782559</pub-id></mixed-citation></ref><ref id="pone.0015684-vonHerrath1"><label>50</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>von Herrath</surname><given-names>M</given-names></name><name><surname>Sanda</surname><given-names>S</given-names></name><name><surname>Herold</surname><given-names>K</given-names></name></person-group>             <year>2007</year>             <article-title>Type 1 diabetes as a relapsing-remitting disease?</article-title>             <source>Nat Rev Immunol</source>             <volume>7</volume>             <fpage>988</fpage>             <lpage>994</lpage>          <pub-id pub-id-type="pmid">17982429</pub-id></mixed-citation></ref><ref id="pone.0015684-Bluestone2"><label>51</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Bluestone</surname><given-names>JA</given-names></name><name><surname>Abbas</surname><given-names>AK</given-names></name></person-group>             <year>2003</year>             <article-title>Natural versus adaptive regulatory T cells.</article-title>             <source>Nat Rev Immunol</source>             <volume>3</volume>             <fpage>253</fpage>             <lpage>257</lpage>          <pub-id pub-id-type="pmid">12658273</pub-id></mixed-citation></ref><ref id="pone.0015684-Raimondi1"><label>52</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Raimondi</surname><given-names>G</given-names></name><name><surname>Turner</surname><given-names>MS</given-names></name><name><surname>Thomson</surname><given-names>AW</given-names></name><name><surname>Morel</surname><given-names>PA</given-names></name></person-group>             <year>2007</year>             <article-title>Naturally occurring regulatory T cells: recent insights in health and disease.</article-title>             <source>Crit Rev Immunol</source>             <volume>27</volume>             <fpage>61</fpage>             <lpage>95</lpage>          <pub-id pub-id-type="pmid">17430097</pub-id></mixed-citation></ref><ref id="pone.0015684-Pandiyan2"><label>53</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Pandiyan</surname><given-names>P</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Ishihara</surname><given-names>S</given-names></name><name><surname>Reed</surname><given-names>J</given-names></name><name><surname>Lenardo</surname><given-names>MJ</given-names></name></person-group>             <year>2007</year>             <article-title>CD4<sup>&#x0002b;</sup>CD25<sup>&#x0002b;</sup>Foxp3<sup>&#x0002b;</sup> regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4<sup>&#x0002b;</sup> T cells.</article-title>             <source>Nat Immunol</source>             <volume>8</volume>             <fpage>1353</fpage>             <lpage>1362</lpage>          <pub-id pub-id-type="pmid">17982458</pub-id></mixed-citation></ref><ref id="pone.0015684-Malek1"><label>54</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Malek</surname><given-names>TR</given-names></name><name><surname>Bayer</surname><given-names>AL</given-names></name></person-group>             <year>2004</year>             <article-title>Tolerance, not immunity, crucially depends on IL-2.</article-title>             <source>Nat Rev Immunol</source>             <volume>4</volume>             <fpage>665</fpage>             <lpage>674</lpage>          <pub-id pub-id-type="pmid">15343366</pub-id></mixed-citation></ref><ref id="pone.0015684-Nelson1"><label>55</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Nelson</surname><given-names>BH</given-names></name></person-group>             <year>2004</year>             <article-title>IL-2, regulatory T cells, and tolerance.</article-title>             <source>J Immunol</source>             <volume>172</volume>             <fpage>3983</fpage>             <lpage>3988</lpage>          <pub-id pub-id-type="pmid">15034008</pub-id></mixed-citation></ref><ref id="pone.0015684-Tang2"><label>56</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Tang</surname><given-names>Q</given-names></name><name><surname>Adams</surname><given-names>JY</given-names></name><name><surname>Penaranda</surname><given-names>C</given-names></name><name><surname>Melli</surname><given-names>K</given-names></name><name><surname>Piaggio</surname><given-names>E</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction.</article-title>             <source>Immunity</source>             <volume>28</volume>             <fpage>687</fpage>             <lpage>697</lpage>          <pub-id pub-id-type="pmid">18468463</pub-id></mixed-citation></ref><ref id="pone.0015684-Serreze1"><label>57</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Serreze</surname><given-names>DV</given-names></name><name><surname>Hamaguchi</surname><given-names>K</given-names></name><name><surname>Leiter</surname><given-names>EH</given-names></name></person-group>             <year>1989</year>             <article-title>Immunostimulation circumvents diabetes in NOD/Lt mice.</article-title>             <source>J Autoimmun</source>             <volume>2</volume>             <fpage>759</fpage>             <lpage>776</lpage>          <pub-id pub-id-type="pmid">2533502</pub-id></mixed-citation></ref><ref id="pone.0015684-Bienvenu1"><label>58</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Bienvenu</surname><given-names>B</given-names></name><name><surname>Martin</surname><given-names>B</given-names></name><name><surname>Auffray</surname><given-names>C</given-names></name><name><surname>Cordier</surname><given-names>C</given-names></name><name><surname>Becourt</surname><given-names>C</given-names></name><etal/></person-group>             <year>2005</year>             <article-title>Peripheral CD8&#x0002b;CD25&#x0002b; T lymphocytes from MHC class II-deficient mice exhibit regulatory activity.</article-title>             <source>J Immunol</source>             <volume>175</volume>             <fpage>246</fpage>             <lpage>253</lpage>          <pub-id pub-id-type="pmid">15972655</pub-id></mixed-citation></ref><ref id="pone.0015684-Khoruts1"><label>59</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Khoruts</surname><given-names>A</given-names></name><name><surname>Mondino</surname><given-names>A</given-names></name><name><surname>Pape</surname><given-names>KA</given-names></name><name><surname>Reiner</surname><given-names>SL</given-names></name><name><surname>Jenkins</surname><given-names>MK</given-names></name></person-group>             <year>1998</year>             <article-title>A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism.</article-title>             <source>J Exp Med</source>             <volume>187</volume>             <fpage>225</fpage>             <lpage>236</lpage>          <pub-id pub-id-type="pmid">9432980</pub-id></mixed-citation></ref><ref id="pone.0015684-Thornton2"><label>60</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Thornton</surname><given-names>AM</given-names></name><name><surname>Shevach</surname><given-names>EM</given-names></name></person-group>             <year>2000</year>             <article-title>Suppressor effector function of CD4&#x0002b; CD25&#x0002b; immunoregulatory T cells is antigen nonspecific.</article-title>             <source>J Immunol</source>             <volume>164</volume>             <fpage>183</fpage>             <lpage>190</lpage>          <pub-id pub-id-type="pmid">10605010</pub-id></mixed-citation></ref><ref id="pone.0015684-PearlYafe2"><label>61</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Pearl-Yafe</surname><given-names>M</given-names></name><name><surname>Yolcu</surname><given-names>ES</given-names></name><name><surname>Stein</surname><given-names>J</given-names></name><name><surname>Kaplan</surname><given-names>O</given-names></name><name><surname>Yaniv</surname><given-names>I</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>Fas ligand enhances hematopoietic cell engraftment through abrogation of alloimmune responses and nonimmunogenic interactions.</article-title>             <source>Stem Cells</source>             <volume>25</volume>             <fpage>1448</fpage>             <lpage>1455</lpage>          <pub-id pub-id-type="pmid">17363551</pub-id></mixed-citation></ref><ref id="pone.0015684-Yarkoni2"><label>62</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Yarkoni</surname><given-names>S</given-names></name><name><surname>Kaminitz</surname><given-names>A</given-names></name><name><surname>Sagiv</surname><given-names>Y</given-names></name><name><surname>Askenasy</surname><given-names>N</given-names></name></person-group>             <year>2010</year>             <article-title>Targeting of IL-2 receptor with a caspase fusion protein disrupts autoimmunity in prediabetic and diabetic NOD mice.</article-title>             <source>Diabetologia</source>             <volume>53</volume>             <fpage>356</fpage>             <lpage>368</lpage>          <pub-id pub-id-type="pmid">19946662</pub-id></mixed-citation></ref><ref id="pone.0015684-Kaminitz1"><label>63</label><mixed-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Kaminitz</surname><given-names>A</given-names></name><name><surname>Mizrahi</surname><given-names>K</given-names></name><name><surname>Yaniv</surname><given-names>I</given-names></name><name><surname>Stein</surname><given-names>J</given-names></name><name><surname>Askenasy</surname><given-names>N</given-names></name></person-group>             <year>2010</year>             <article-title>Immunosuppressive therapy exacerbates autoimmunity in NOD mice and diminishes the protective activity of regulatory T cells.</article-title>             <source>J Autoimmun</source>             <volume>35</volume>             <fpage>145</fpage>             <lpage>152</lpage>          <pub-id pub-id-type="pmid">20638242</pub-id></mixed-citation></ref></ref-list></back></article>